Fluorescence Guided Surgery Systems Market Share

North America Market Analysis

North America fluorescence guided surgery systems market is expected to capture revenue share of over 58.5% by 2037. The growth is driven by the presence of advanced healthcare facilities across the region and the increasing patient population. The governing authorities such as FDA and other institutions are also supporting the progress in this sector through accelerated approvals and funding for FGS products. This is further encouraging domestic leaders to leverage their development and distribution in this field. For instance, in April 2021, OnLume raised a Series A funding of USD 7 million to assist its commercial launch of the FIS system. In addition to the Phase II SBIR grant of USD 2 million from the NIH in 2020, this financial support was dedicated to gathering sufficient resources for future growth.

The U.S. is at the forefront of the regional fluorescence guided surgery systems market due to massive economic growth. As the people of this country become more economically stable, they become eligible to afford such advanced treatments. This creates a good marketplace for this sector and inspires domestic leaders to bring innovation in this field. For instance, in August 2024, SurgicalOne, Inc. partnered with Getinge USA Sales, LLC to help surgeons with greater precision, efficiency, and safety through autofluorescence and fluorescence imaging technology. The team aims to promote advanced imaging solutions by Fluoptics for thyroid/parathyroid and plastic surgery procedures.

Canada is also showing interest in investing in domestic progress in the fluorescence guided surgery systems market by engaging supportive regulations and releasing grants and incentives for R&D. According to a CCS report, published in May 2024, the estimated number of new cancer and death cases was accounted to be 247,100 and 88,100 in the same year. Thus, the country is proactively putting efforts on enhancing healthcare infrastructure to control the growing cancer prevalence. For instance, in January 2023, the Government of Canada announced funding of USD 23 million in childhood cancer research to secure the future generation from this disease. This is influencing global leaders to augment this sector with innovations.

APAC Market Statistics

Asia Pacific is growing significantly in the fluorescence guided surgery systems market with the concerning prevalence cases and extensive R&D efforts to fight against it. The developing countries such as India, Japan, China, and Australia are cultivating resources to develop a well-established healthcare ecosystem across the region. This is creating great opportunities for global leaders to expand their portfolio. For instance, in September 2024, Stryker launched an advanced imaging platform, 1788 to elevate with enhanced imaging capabilities. The new launch aims to solidify the company’s reach throughout the country by elevating surgical visualization across various medical specialties.

India is fostering its own developmental forces to participate in the global fluorescence guided surgery systems market through innovations. According to the 2023 World Bank report, around USD 24.0 million worth of synthetic organic products, used as fluorescent were imported to the country. This is evidence of utilizing such substrates for healthcare innovations. For instance, in August 2024, PIB announced that a team of researchers in IASST developed an affordable, user-friendly, portable smartphone-based fluorescence turn-on sensor system to assist in Parkinson's disease management. Such innovations are setting an example for other domestic leaders to explore deeper in this field.

China is also augmenting regional growth by generating remarkable revenue from the fluorescence guided surgery systems market. Rising demand for advanced imaging and surgical techniques to empower the healthcare infrastructure is fueling the industry. The increasing medical expenditure in the country sets a high hope for established traders in this field. Many domestic medical instrument leaders are also showing interest in investing in R&D to introduce innovative modules.